We’ve recently updated our valuation analysis.

Barfresh Food Group Valuation

Is BRFH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BRFH?

Other financial metrics that can be useful for relative valuation.

BRFH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.4x
Enterprise Value/EBITDA-3.7x
PEG Ration/a

Price to Sales Ratio vs Peers

How does BRFH's PS Ratio compare to its peers?

The above table shows the PS ratio for BRFH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average0.4x
SNAX Stryve Foods
0.5x33.1%US$19.7m
LSF Laird Superfood
0.4x9.2%US$12.9m
BTTR Better Choice
0.4x17.2%US$24.7m
FAMI Farmmi
0.2xn/aUS$13.0m
BRFH Barfresh Food Group
1.7x31.9%US$17.5m

Price-To-Sales vs Peers: BRFH is expensive based on its Price-To-Sales Ratio (1.7x) compared to the peer average (0.4x).


Price to Earnings Ratio vs Industry

How does BRFH's PE Ratio compare vs other companies in the US Food Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a9.9%
n/an/an/a

Price-To-Sales vs Industry: BRFH is expensive based on its Price-To-Sales Ratio (1.7x) compared to the US Food industry average (1.1x)


Price to Sales Ratio vs Fair Ratio

What is BRFH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BRFH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.7x
Fair PS Ratio1x

Price-To-Sales vs Fair Ratio: BRFH is expensive based on its Price-To-Sales Ratio (1.7x) compared to the estimated Fair Price-To-Sales Ratio (1x).


Share Price vs Fair Value

What is the Fair Price of BRFH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BRFH's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BRFH's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BRFH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$1.35
US$5.25
+288.9%
4.8%US$5.50US$5.00n/a2
Nov ’23US$1.87
US$10.50
+461.5%
23.8%US$13.00US$8.00n/a2
Oct ’23US$2.90
US$10.50
+262.1%
23.8%US$13.00US$8.00n/a2
Sep ’23US$3.32
US$10.50
+216.3%
23.8%US$13.00US$8.00n/a2
Aug ’23US$4.38
US$10.50
+139.7%
23.8%US$13.00US$8.00n/a2
Jul ’23US$5.23
US$10.50
+100.8%
23.8%US$13.00US$8.00n/a2
Jun ’23US$5.08
US$10.50
+106.9%
23.8%US$13.00US$8.00n/a2
May ’23US$6.76
US$10.50
+55.4%
23.8%US$13.00US$8.00n/a2
Apr ’23US$7.34
US$11.00
+49.9%
18.2%US$13.00US$9.00n/a2
Mar ’23US$4.55
US$11.00
+141.8%
18.2%US$13.00US$9.00n/a2
Feb ’23US$5.00
US$11.00
+120.0%
0%US$11.00US$11.00n/a1
Jan ’23US$6.55
US$11.00
+67.9%
0%US$11.00US$11.00n/a1
Dec ’22US$4.29
US$11.05
+157.6%
0%US$11.05US$11.05n/a1
Nov ’22US$4.94
US$11.05
+123.7%
0%US$11.05US$11.05US$1.871
Oct ’22US$5.52
US$11.05
+100.0%
0%US$11.05US$11.05US$2.901
Sep ’22US$5.85
US$11.05
+88.9%
0%US$11.05US$11.05US$3.321
Aug ’22US$7.15
US$11.05
+54.5%
0%US$11.05US$11.05US$4.381
Jul ’22US$7.15
US$11.05
+54.5%
0%US$11.05US$11.05US$5.231
Jun ’22US$6.50
US$7.80
+20.0%
0%US$7.80US$7.80US$5.081
May ’22US$5.91
US$7.80
+31.9%
0%US$7.80US$7.80US$6.761
Apr ’22US$5.85
US$7.80
+33.3%
0%US$7.80US$7.80US$7.341
Mar ’22US$5.46
US$7.80
+42.9%
0%US$7.80US$7.80US$4.551
Feb ’22US$4.94
US$7.80
+57.9%
0%US$7.80US$7.80US$5.001
Jan ’22US$5.59
US$7.80
+39.5%
0%US$7.80US$7.80US$6.551
Dec ’21US$3.12
US$7.80
+149.7%
0%US$7.80US$7.80US$4.291
Nov ’21US$3.25
US$13.00
+300.0%
0%US$13.00US$13.00US$4.941

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies